Ceribell

CBLLNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$713.702 M

$18.81 +3.07%

Close of 7 Aug 2026

Revenue

$89.1M

#2555 by revenue

Earnings

-$53.4M

Loss-making

Shares outstanding

37,942,700

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus — ranked by market cap

All 28 →

#7CONMEDCNMD$1.47B
#8InModeINMD$970.0M
#9CeribellCBLL$713.7M
#10CapsoVisionCV$354.7M
#11ElectromedELMD$349.3M

Where these numbers come from

Share counts and financials for Ceribell are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.